Clinic
California Urgent Care Center Professional Corporation
California Urgent Care Center Professional Corporation was paid $19.59M by Medicaid between Jan 2018 and Dec 2024, across 65 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 32% of everything it billed.
33Billing provider infoCALIFORNIA URGENT CARE CENTER PROFESSIONAL CORPORATION
STOCKTON, CA 95210
STOCKTON, CA 95210
33aNPI1588959084assigned 06/13/2011
33bProvider typeUrgent Care Clinic/Center
28Total paid$19.59M
24GClaims600,927
24DCodes billed65
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Urgent Care Clinic/Center providers in California
Rank by total paid#10 of 284
Median peer was paid$147K
This provider vs. median133×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 113,020 | $4.02M | |
| 2019 | 75,596 | $2.31M | |
| 2020 | 60,373 | $1.95M | |
| 2021 | 86,842 | $2.77M | |
| 2022 | 103,735 | $3.25M | |
| 2023 | 87,525 | $2.77M | |
| 2024incomplete | 73,836 | $2.52M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 32% | 149,189 | 138,429 | $6.33M |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 22% | 54,994 | 54,156 | $4.25M |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 10% | 33,540 | 33,249 | $2.04M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 9.6% | 70,273 | 64,707 | $1.88M |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 9.4% | 55,742 | 50,461 | $1.83M |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 5.2% | 40,762 | 38,374 | $1.01M |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 1.7% | 19,434 | 18,401 | $334K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 1.3% | 15,280 | 14,052 | $248K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.2% | 17,000 | 14,526 | $240K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 5,072 | 4,903 | $195K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 7,043 | 6,862 | $166K |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 6,245 | 5,548 | $126K |
53 more codes
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 17,937 | $122K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 8,291 | $95K |
| 99354 | <1% | 1,576 | $87K | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 7,335 | $76K |
| A7003 | Administration set, with small volume nonfiltered pneumatic nebulizer, disposable | <1% | 2,157 | $61K |
| 87428 | <1% | 989 | $59K | |
| 93000 | <1% | 2,081 | $57K | |
| 81003 | <1% | 26,968 | $49K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 1,980 | $43K |
| 69209 | <1% | 3,319 | $34K | |
| 87807 | <1% | 3,065 | $25K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 357 | $21K |
| 81025 | <1% | 6,962 | $21K | |
| 29515 | <1% | 373 | $19K | |
| A7016 | Dome and mouthpiece, used with small volume ultrasonic nebulizer | <1% | 3,514 | $19K |
| 90714 | <1% | 646 | $18K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 333 | $16K |
| 29125 | <1% | 254 | $13K | |
| 29280 | <1% | 274 | $9K | |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | <1% | 947 | $9K |
| 94760 | <1% | 2,711 | $7K | |
| 29530 | <1% | 210 | $5K | |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | <1% | 573 | $5K |
| A6449 | Light compression bandage, elastic, knitted/woven, width greater than or equal to three inches and less than five inches, per yard | <1% | 1,533 | $5K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 588 | $5K |
| 81002 | <1% | 2,071 | $5K | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 437 | $4K |
| 69210 | <1% | 141 | $4K | |
| 10060 | <1% | 101 | $4K | |
| 82947 | <1% | 1,425 | $4K | |
| 85018 | <1% | 2,125 | $4K | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 208 | $4K |
| 29260 | <1% | 121 | $4K | |
| 29540 | <1% | 254 | $4K | |
| S0077 | Injection, clindamycin phosphate, 300 mg | <1% | 262 | $3K |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 399 | $3K |
| 99051 | <1% | 9,417 | $3K | |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | <1% | 290 | $2K |
| 86308 | <1% | 383 | $2K | |
| 12001 | <1% | 24 | $2K | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 14 | $1K |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 7,932 | $1K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 34 | $1K |
| 11730 | <1% | 30 | $897.52 | |
| S0119 | Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) | <1% | 318 | $883.99 |
| 99072 | <1% | 4,801 | $801.25 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 150 | $756.92 |
| 99000 | <1% | 220 | $711.87 | |
| 29130 | <1% | 25 | $615.72 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 19 | $505.26 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 15 | $392.98 |
| J7644 | Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | <1% | 151 | $199.40 |
| J3490 | Unclassified drugs | <1% | 13 | $60.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGEORGIES, RAMI (OWNER)
| Provider | Location | Paid |
|---|---|---|
| Mercy West Urgent Care INC | Turlock, CA | $3.54M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.